Breaking News Instant updates and real-time market news.

GMLP

Golar LNG Partners

$2.75 /

+0.32 (+13.17%)

08:06
05/28/20
05/28
08:06
05/28/20
08:06

Golar LNG Partners reports Q1 operating revenue $69.8M, consensus $71.76M

The company said, "Covid-19 has added significant downward pressure to LNG prices, resulting in intra-basin LNG trade over inter-basin trade. Although this has been negative for the overall shipping balance, this trade pattern is better suited to the Golar Maria and Golar Grand and will have contributed to their high utilization levels, despite the challenging market. Current LNG prices compare favourably to other sources of energy, including pipeline gas, coal, heavy fuel oil and diesel. This is expected to result in increased utilization levels on FSRUs that might normally only be used as backup for, or to supplement, other energy sources. These same historically low gas prices are introducing new buyers and creating new markets for LNG - markets that have, in some cases, recently had their first taste of clean air in a generation. FSRUs are a quick delivering, low-cost, flexible alternative infrastructure solution that can meet the needs of these markets. Together with other opportunities being developed by Golar Power Limited, the Partnership is therefore highly confident that it will re-contract its currently contracted FSRU fleet once their contracts start to expire in 2022/3. Having extended the bond maturities, attention will return once again to the review of the Partnership's strategic alternatives including structure and strategy to better use the $2.0 billion of revenue backlog1 to maximize long-term shareholder value. This could include the sale of assets, for which unsolicited offers have been received. In the meantime, second quarter results will be positively impacted by a full quarter's contribution from the Golar Igloo, partly mitigated by reduced rates achieved in respect of the Golar Maria."

  • 28

    May

GMLP Golar LNG Partners
$2.75 /

+0.32 (+13.17%)

04/02/20 Stifel
Golar LNG Partners shares offer 'compelling' valuation, says Stifel
04/02/20 B. Riley Securities
Golar LNG Partners price target lowered to $4 from $10 at B. Riley FBR
04/02/20 Evercore ISI
Golar LNG Partners downgraded to In Line from Outperform at Evercore ISI
02/26/20 Odeon Capital
Golar LNG Partners upgraded to Hold from Sell at Odeon Capital

TODAY'S FREE FLY STORIES

Periodicals
Trump lifting COVID travel restrictions on Europe/Brazil, Reuters reports » 18:22
01/18/21
01/18
18:22
01/18/21
18:22
ALK

Alaska Air

$53.64 /

-1.75 (-3.16%)

, LUV

Southwest

$46.65 /

-2.18 (-4.46%)

, DAL

Delta Air Lines

$39.96 /

-1.5 (-3.62%)

, JBLU

JetBlue

$14.93 /

-0.78 (-4.96%)

, UAL

United Airlines

$43.88 /

-2.42 (-5.23%)

, SAVE

Spirit Airlines

$25.74 /

-1.45 (-5.33%)

, AAL

American Airlines

$15.77 /

-0.665 (-4.05%)

President Donald Trump…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALK Alaska Air
$53.64 /

-1.75 (-3.16%)

LUV Southwest
$46.65 /

-2.18 (-4.46%)

DAL Delta Air Lines
$39.96 /

-1.5 (-3.62%)

JBLU JetBlue
$14.93 /

-0.78 (-4.96%)

UAL United Airlines
$43.88 /

-2.42 (-5.23%)

SAVE Spirit Airlines
$25.74 /

-1.45 (-5.33%)

AAL American Airlines
$15.77 /

-0.665 (-4.05%)

ALK Alaska Air
$53.64 /

-1.75 (-3.16%)

01/14/21 Susquehanna
Alaska Air price target raised to $60 from $50 at Susquehanna
01/14/21 Susquehanna
Susquehanna cuts Delta to Neutral on international and business travel risks
12/11/20 UBS
Alaska Air upgraded to Buy from Neutral at UBS
12/11/20 Deutsche Bank
Alaska Air downgraded to Hold from Buy at Deutsche Bank
LUV Southwest
$46.65 /

-2.18 (-4.46%)

01/14/21 Susquehanna
Southwest price target raised to $60 from $50 at Susquehanna
01/14/21 Susquehanna
Susquehanna cuts Delta to Neutral on international and business travel risks
12/23/20 Citi
Airline demand in early 2021 'looks soft,' says Citi
12/11/20 Deutsche Bank
Southwest downgraded to Hold from Buy at Deutsche Bank
DAL Delta Air Lines
$39.96 /

-1.5 (-3.62%)

01/15/21 Vertical Research
Vertical Research upgrades Delta to Buy, sees potential triple in next 5 years
01/15/21 Vertical Research
Delta Air Lines upgraded to Buy from Hold at Vertical Research
01/15/21 Morgan Stanley
Delta Air Lines price target raised to $55 from $51 at Morgan Stanley
01/14/21
Fly Intel: Top five analyst downgrades
JBLU JetBlue
$14.93 /

-0.78 (-4.96%)

01/15/21
Fly Intel: Top five analyst downgrades
01/15/21 Vertical Research
JetBlue downgraded to Hold on 'capex ramp' at Vertical Research
01/15/21 Vertical Research
JetBlue downgraded to Hold from Buy at Vertical Research
01/14/21 Susquehanna
JetBlue price target raised to $15 from $12 at Susquehanna
UAL United Airlines
$43.88 /

-2.42 (-5.23%)

01/14/21 Susquehanna
United Airlines price target raised to $40 from $38 at Susquehanna
01/11/21 Cowen
United Airlines upgraded to Outperform from Market Perform at Cowen
01/08/21
Fly Intel: Top five analyst downgrades
01/08/21 BofA
United Airlines downgraded to Underperform from Neutral at BofA
SAVE Spirit Airlines
$25.74 /

-1.45 (-5.33%)

01/14/21 Susquehanna
Spirit Airlines price target raised to $22 from $19 at Susquehanna
01/08/21 BofA
Spirit Airlines upgraded to Neutral from Underperform at BofA
12/23/20 Citi
Airline demand in early 2021 'looks soft,' says Citi
12/16/20
Fly Intel: Top five analyst downgrades
AAL American Airlines
$15.77 /

-0.665 (-4.05%)

01/14/21 Susquehanna
American Airlines price target raised to $10 from $8 at Susquehanna
01/11/21 Cowen
American Airlines downgraded to Market Perform from Outperform at Cowen
12/23/20 Citi
Airline demand in early 2021 'looks soft,' says Citi
12/11/20 Deutsche Bank
American Airlines downgraded to Hold from Buy at Deutsche Bank
ALK Alaska Air
$53.64 /

-1.75 (-3.16%)

LUV Southwest
$46.65 /

-2.18 (-4.46%)

DAL Delta Air Lines
$39.96 /

-1.5 (-3.62%)

JBLU JetBlue
$14.93 /

-0.78 (-4.96%)

UAL United Airlines
$43.88 /

-2.42 (-5.23%)

SAVE Spirit Airlines
$25.74 /

-1.45 (-5.33%)

AAL American Airlines
$15.77 /

-0.665 (-4.05%)

  • 02
    Dec
  • 10
    Nov
  • 23
    Jun
  • 08
    May
  • 29
    Apr
  • 22
    Apr
ALK Alaska Air
$53.64 /

-1.75 (-3.16%)

LUV Southwest
$46.65 /

-2.18 (-4.46%)

DAL Delta Air Lines
$39.96 /

-1.5 (-3.62%)

JBLU JetBlue
$14.93 /

-0.78 (-4.96%)

UAL United Airlines
$43.88 /

-2.42 (-5.23%)

SAVE Spirit Airlines
$25.74 /

-1.45 (-5.33%)

AAL American Airlines
$15.77 /

-0.665 (-4.05%)

ALK Alaska Air
$53.64 /

-1.75 (-3.16%)

LUV Southwest
$46.65 /

-2.18 (-4.46%)

DAL Delta Air Lines
$39.96 /

-1.5 (-3.62%)

JBLU JetBlue
$14.93 /

-0.78 (-4.96%)

UAL United Airlines
$43.88 /

-2.42 (-5.23%)

SAVE Spirit Airlines
$25.74 /

-1.45 (-5.33%)

AAL American Airlines
$15.77 /

-0.665 (-4.05%)

ALK Alaska Air
$53.64 /

-1.75 (-3.16%)

LUV Southwest
$46.65 /

-2.18 (-4.46%)

DAL Delta Air Lines
$39.96 /

-1.5 (-3.62%)

JBLU JetBlue
$14.93 /

-0.78 (-4.96%)

UAL United Airlines
$43.88 /

-2.42 (-5.23%)

SAVE Spirit Airlines
$25.74 /

-1.45 (-5.33%)

AAL American Airlines
$15.77 /

-0.665 (-4.05%)

Hot Stocks
Turquoise Hill reports 2020 copper production of149,631 tonnes » 18:17
01/18/21
01/18
18:17
01/18/21
18:17
TRQ

Turquoise Hill

$11.96 /

-0.385 (-3.12%)

Turquoise Hill Resources…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRQ Turquoise Hill
$11.96 /

-0.385 (-3.12%)

TRQ Turquoise Hill
$11.96 /

-0.385 (-3.12%)

01/11/21 Scotiabank
Turquoise Hill price target raised to C$27 from C$22.50 at Scotiabank
01/08/21 Canaccord
Turquoise Hill price target raised to C$18.50 from C$13.50 at Canaccord
01/04/21 BMO Capital
Turquoise Hill initiated with an Outperform at BMO Capital
12/17/20 Scotiabank
Turquoise Hill price target raised to C$22.50 from C$20 at Scotiabank
TRQ Turquoise Hill
$11.96 /

-0.385 (-3.12%)

TRQ Turquoise Hill
$11.96 /

-0.385 (-3.12%)

Upgrade
Brown & Brown upgraded to Outperform from Market Perform at Keefe Bruyette » 18:13
01/18/21
01/18
18:13
01/18/21
18:13
BRO

Brown & Brown

$46.32 /

+0.595 (+1.30%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRO Brown & Brown
$46.32 /

+0.595 (+1.30%)

BRO Brown & Brown
$46.32 /

+0.595 (+1.30%)

01/15/21 Deutsche Bank
Brown & Brown named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/08/21 Goldman Sachs
Brown & Brown upgraded to Buy from Neutral at Goldman Sachs
12/31/20 Credit Suisse
Brown & Brown price target raised to $50 from $47 at Credit Suisse
12/14/20 Deutsche Bank
Brown & Brown price target raised to $50 from $47 at Deutsche Bank
BRO Brown & Brown
$46.32 /

+0.595 (+1.30%)

Recommendations
PNC Financial price target raised to $167 from $150 at Keefe Bruyette » 18:11
01/18/21
01/18
18:11
01/18/21
18:11
PNC

PNC Financial

$154.85 /

-4.72 (-2.96%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

01/13/21 Piper Sandler
PNC Financial downgraded to Neutral from Overweight at Piper Sandler
01/11/21 Citi
PNC Financial upgraded to Buy from Neutral at Citi
01/11/21 Citi
PNC Financial upgraded to Buy from Neutral at Citi
01/06/21 Deutsche Bank
PNC Financial price target raised to $157 from $115 at Deutsche Bank
PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

PNC PNC Financial
$154.85 /

-4.72 (-2.96%)

Hot Stocks
Cardiovascular Systems receives CE Mark for Diamondback 360 » 18:04
01/18/21
01/18
18:04
01/18/21
18:04
CSII

Cardiovascular Systems

$44.73 /

-0.87 (-1.91%)

Cardiovascular Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSII Cardiovascular Systems
$44.73 /

-0.87 (-1.91%)

CSII Cardiovascular Systems
$44.73 /

-0.87 (-1.91%)

12/16/20 Northland
Cardiovascular Systems price target raised to $45 from $40 at Northland
08/17/20 Barclays
Cardiovascular Systems offers 'significant upside opportunity,' says Barclays
07/22/20
Fly Intel: Top five analyst initiations
07/22/20 Northland
Cardiovascular Systems initiated with an Outperform at Northland
CSII Cardiovascular Systems
$44.73 /

-0.87 (-1.91%)

  • 10
    Jun
Hot Stocks
Resolute Forest names Sylvain Girard as CFO » 18:03
01/18/21
01/18
18:03
01/18/21
18:03
RFP

Resolute Forest

$7.50 /

+0.09 (+1.21%)

Resolute Forest Products…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RFP Resolute Forest
$7.50 /

+0.09 (+1.21%)

RFP Resolute Forest
$7.50 /

+0.09 (+1.21%)

12/18/20 CIBC
Resolute Forest upgraded to Outperformer from Neutral at CIBC
08/19/20 RBC Capital
Resolute Forest upgraded to Outperform from Sector Perform at RBC Capital
08/19/20 RBC Capital
Resolute Forest upgraded to Outperform from Sector Perform at RBC Capital
07/31/20
Fly Intel: Top five analyst downgrades
RFP Resolute Forest
$7.50 /

+0.09 (+1.21%)

RFP Resolute Forest
$7.50 /

+0.09 (+1.21%)

RFP Resolute Forest
$7.50 /

+0.09 (+1.21%)

Recommendations
KLA Corp. price target raised to $308 from $271 at Goldman Sachs » 18:01
01/18/21
01/18
18:01
01/18/21
18:01
KLAC

KLA Corp.

$304.26 /

+0.56 (+0.18%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KLAC KLA Corp.
$304.26 /

+0.56 (+0.18%)

KLAC KLA Corp.
$304.26 /

+0.56 (+0.18%)

01/08/21 Argus
KLA Corp. price target raised to $300 from $235 at Argus
01/06/21 KeyBanc
KLA Corp. price target raised to $293 from $266 at KeyBanc
12/17/20 Deutsche Bank
KLA Corp. price target raised to $250 from $205 at Deutsche Bank
12/16/20 JPMorgan
Semiconductor equipment shares have further upside, says JPMorgan
KLAC KLA Corp.
$304.26 /

+0.56 (+0.18%)

KLAC KLA Corp.
$304.26 /

+0.56 (+0.18%)

KLAC KLA Corp.
$304.26 /

+0.56 (+0.18%)

KLAC KLA Corp.
$304.26 /

+0.56 (+0.18%)

Recommendations
Entegris price target raised to $116 from $102 at Goldman Sachs » 17:59
01/18/21
01/18
17:59
01/18/21
17:59
ENTG

Entegris

$107.62 /

-0.83 (-0.77%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENTG Entegris
$107.62 /

-0.83 (-0.77%)

ENTG Entegris
$107.62 /

-0.83 (-0.77%)

12/14/20 Goldman Sachs
Entegris price target raised to $102 from $89 at Goldman Sachs
12/08/20 Stifel
Entegris price target raised to $115 from $91 at Stifel
12/01/20 Stifel
Micron's Q1 preannouncement supports recent Stifel channel checks
11/18/20 KeyBanc
Entegris price target raised to $105 from $90 at KeyBanc
ENTG Entegris
$107.62 /

-0.83 (-0.77%)

Recommendations
Teradyne price target raised to $150 from $128 at Goldman Sachs » 17:58
01/18/21
01/18
17:58
01/18/21
17:58
TER

Teradyne

$137.39 /

-0.98 (-0.71%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TER Teradyne
$137.39 /

-0.98 (-0.71%)

TER Teradyne
$137.39 /

-0.98 (-0.71%)

01/11/21 BofA
Teradyne upgraded to Buy from Neutral at BofA
01/06/21 KeyBanc
Teradyne price target raised to $138 from $115 at KeyBanc
12/17/20 Deutsche Bank
Teradyne price target raised to $130 from $110 at Deutsche Bank
12/14/20 Goldman Sachs
Teradyne price target raised to $128 from $107 at Goldman Sachs
TER Teradyne
$137.39 /

-0.98 (-0.71%)

TER Teradyne
$137.39 /

-0.98 (-0.71%)

TER Teradyne
$137.39 /

-0.98 (-0.71%)

Recommendations
Lam Research price target raised to $616 from $557 at Goldman Sachs » 17:58
01/18/21
01/18
17:58
01/18/21
17:58
LRCX

Lam Research

$547.85 /

-9.93 (-1.78%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
$547.85 /

-9.93 (-1.78%)

LRCX Lam Research
$547.85 /

-9.93 (-1.78%)

01/11/21 BofA
BofA US 1 List changes
01/08/21
Fly Intel: Top five analyst downgrades
01/08/21 Needham
Lam Research valuation 'full,' downgraded to Hold from Buy at Needham
01/08/21 Needham
Lam Research downgraded to Hold from Buy at Needham
LRCX Lam Research
$547.85 /

-9.93 (-1.78%)

LRCX Lam Research
$547.85 /

-9.93 (-1.78%)

LRCX Lam Research
$547.85 /

-9.93 (-1.78%)

LRCX Lam Research
$547.85 /

-9.93 (-1.78%)

Recommendations
Applied Materials price target raised to $118 from $99 at Goldman Sachs » 17:57
01/18/21
01/18
17:57
01/18/21
17:57
AMAT

Applied Materials

$103.17 /

-2.64 (-2.50%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMAT Applied Materials
$103.17 /

-2.64 (-2.50%)

AMAT Applied Materials
$103.17 /

-2.64 (-2.50%)

01/11/21 BofA
BofA US 1 List changes
01/07/21 Argus
Applied Materials price target raised to $110 from $90 at Argus
01/06/21 KeyBanc
Applied Materials price target raised to $104 from $89 at KeyBanc
01/05/21 RBC Capital
Applied Materials price target raised to $95 from $82 at RBC Capital
AMAT Applied Materials
$103.17 /

-2.64 (-2.50%)

AMAT Applied Materials
$103.17 /

-2.64 (-2.50%)

AMAT Applied Materials
$103.17 /

-2.64 (-2.50%)

AMAT Applied Materials
$103.17 /

-2.64 (-2.50%)

Upgrade
CMC Materials upgraded to Neutral from Sell at Goldman Sachs » 17:57
01/18/21
01/18
17:57
01/18/21
17:57
CCMP

CMC Materials

$164.54 /

-3.28 (-1.95%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCMP CMC Materials
$164.54 /

-3.28 (-1.95%)

CCMP CMC Materials
$164.54 /

-3.28 (-1.95%)

11/13/20
Fly Intel: Top five analyst downgrades
11/13/20 Loop Capital
CMC Materials price target lowered to $170 from $187 at Loop Capital
11/13/20 Citi
CMC Materials downgraded to Sell from Neutral at Citi
10/15/20 CL King
CMC Materials FY20 EPS estimate raised to $7.23 at CL King
CCMP CMC Materials
$164.54 /

-3.28 (-1.95%)

Downgrade
Alimentation downgraded to Market Perform from Outperform at BMO Capital » 17:52
01/18/21
01/18
17:52
01/18/21
17:52
ANCUF

Alimentation Couche-Tard

$0.00 /

+ (+0.00%)

, CRRFY

Carrefour

$0.00 /

+ (+0.00%)

BMO Capital analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

CRRFY Carrefour
$0.00 /

+ (+0.00%)

ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

01/15/21 CIBC
Alimentation Couche-Tard price target lowered to C$46 from C$52 at CIBC
01/15/21 Barclays
Alimentation Couche-Tard downgraded to Equal Weight from Overweight at Barclays
01/08/21 TD Securities
Alimentation Couche-Tard downgraded to Hold from Buy at TD Securities
12/01/20 Goldman Sachs
Alimentation Couche-Tard initiated with a Neutral at Goldman Sachs
CRRFY Carrefour
$0.00 /

+ (+0.00%)

01/15/21 Barclays
Alimentation Couche-Tard downgraded to Equal Weight from Overweight at Barclays
10/12/20 JPMorgan
Carrefour should be building momentum in France, says JPMorgan
07/31/20 Berenberg
Carrefour price target raised to EUR 15.10 from EUR 14.80 at Berenberg
06/22/20 JPMorgan
Carrefour upgraded to Overweight from Neutral at JPMorgan
ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

CRRFY Carrefour
$0.00 /

+ (+0.00%)

Hot Stocks
American Campus announces quarterly dividend of 47c » 17:49
01/18/21
01/18
17:49
01/18/21
17:49
ACC

American Campus

$42.99 /

-0.15 (-0.35%)

American Campus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACC American Campus
$42.99 /

-0.15 (-0.35%)

ACC American Campus
$42.99 /

-0.15 (-0.35%)

12/23/20 Piper Sandler
American Campus price target raised to $45 from $38 at Piper Sandler
12/21/20 JPMorgan
JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021
12/21/20 JPMorgan
American Campus downgraded to Underweight from Neutral at JPMorgan
12/15/20 Deutsche Bank
American Campus upgraded to Buy with $49 target at Deutsche Bank
ACC American Campus
$42.99 /

-0.15 (-0.35%)

ACC American Campus
$42.99 /

-0.15 (-0.35%)

Periodicals
Canada scrambles to salvage Keystone XL, Reuters reports » 17:23
01/18/21
01/18
17:23
01/18/21
17:23
TRP

TC Energy

$44.40 /

+0.11 (+0.25%)

U.S. President-elect Joe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRP TC Energy
$44.40 /

+0.11 (+0.25%)

TRP TC Energy
$44.40 /

+0.11 (+0.25%)

01/13/21 CIBC
TC Energy price target lowered to C$71 from C$73 at CIBC
01/12/21 Barclays
TC Energy downgraded to Equal Weight from Overweight at Barclays
01/06/21 BofA
TC Energy downgraded to Neutral from Buy at BofA
01/06/21 BofA
TC Energy downgraded to Neutral from Buy at BofA
TRP TC Energy
$44.40 /

+0.11 (+0.25%)

TRP TC Energy
$44.40 /

+0.11 (+0.25%)

Periodicals
NY Gov. asks Pfizer to directly sell COVID vaccine doses, Reuters reports » 17:19
01/18/21
01/18
17:19
01/18/21
17:19
PFE

Pfizer

$36.70 /

-0.05 (-0.14%)

New York Governor Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.70 /

-0.05 (-0.14%)

PFE Pfizer
$36.70 /

-0.05 (-0.14%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
PFE Pfizer
$36.70 /

-0.05 (-0.14%)

PFE Pfizer
$36.70 /

-0.05 (-0.14%)

PFE Pfizer
$36.70 /

-0.05 (-0.14%)

PFE Pfizer
$36.70 /

-0.05 (-0.14%)

Conference/Events
First Majestic to host conference call » 16:24
01/18/21
01/18
16:24
01/18/21
16:24
AG

First Majestic

$11.82 /

-0.83 (-6.56%)

Management discusses 4Q…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AG First Majestic
$11.82 /

-0.83 (-6.56%)

AG First Majestic
$11.82 /

-0.83 (-6.56%)

01/11/21 National Bank
First Majestic price target raised to C$20 from C$18 at National Bank
10/22/20 National Bank
First Majestic price target lowered to C$18 from C$20 at National Bank
10/20/20 TD Securities
First Majestic upgraded to Buy from Hold at TD Securities
09/11/20 National Bank
First Majestic price target raised to C$20 from C$19 at National Bank
AG First Majestic
$11.82 /

-0.83 (-6.56%)

AG First Majestic
$11.82 /

-0.83 (-6.56%)

AG First Majestic
$11.82 /

-0.83 (-6.56%)

Hot Stocks
CommScope files patent infringement suit against SOLiD in Germany » 16:17
01/18/21
01/18
16:17
01/18/21
16:17
COMM

CommScope

$14.72 /

-0.22 (-1.47%)

CommScope filed an…

CommScope filed an additional patent infringement lawsuit in Germany against SOLiD, a manufacturer of distributed antenna systems based in South Korea. The complaint asserts German part of European Patent No. EP 2290850B1 relating to CommScope's digital DAS innovations against SOLiD's Genesis DAS product. CommScope asserted the United Kingdom part of this patent against SOLiD's Genesis DAS product in the U.K. last year. CommScope also enforced the U.S. counterparts of EP 2290850B1 in separate U.S. patent infringement actions against Dali Wireless and SOLiD. The U.S. action against SOLiD was filed in May of 2020 and, after noting that SOLiD withdrew its Genesis DAS product from the U.S. market, CommScope voluntarily dismissed that action.

ShowHide Related Items >><<
COMM CommScope
$14.72 /

-0.22 (-1.47%)

COMM CommScope
$14.72 /

-0.22 (-1.47%)

12/21/20
Fly Intel: Top five analyst downgrades
12/21/20 Citi
CommScope downgraded to Sell from Neutral at Citi
12/11/20
Fly Intel: Top five analyst upgrades
12/11/20 JPMorgan
CommScope upgraded to Overweight with $18 target at JPMorgan
COMM CommScope
$14.72 /

-0.22 (-1.47%)

COMM CommScope
$14.72 /

-0.22 (-1.47%)

COMM CommScope
$14.72 /

-0.22 (-1.47%)

Earnings
Fly Intel: What to watch in next round of big banks' earnings reports » 16:09
01/18/21
01/18
16:09
01/18/21
16:09
BAC

Bank of America

$33.02 /

-0.97 (-2.85%)

, GS

Goldman Sachs

$301.05 /

-6.95 (-2.26%)

, MS

Morgan Stanley

$75.22 /

-1.25 (-1.63%)

Goldman Sachs (GS) and…

Goldman Sachs (GS) and Bank of America (BAC) are scheduled to announce quarterly results on January 19, while Morgan Stanley (MS) is expected to report on January 20. What to watch for: 1. SELECT OPPORTUNITIES AMONG BANKS: Last week, Citi analyst Keith Horowitz upgraded Bank of America to Buy from Neutral with a price target of $37, up from $31. A steeper curve "should be more readily evident with lower premium am, in addition to securities yield lift," Horowitz told investors in a research note. The analyst sees select opportunities among the banks. Those banks that have outperformed this year aren't the banks that stand to benefit the most from a steeper curve, creating opportunities, he added. 2. POSITIVE EARNINGS SURPRISES: Earlier this month, Barclays analyst Jason Goldberg upgraded Morgan Stanley to Overweight from Equal Weight with a price target of $88, up from $60. The analyst told investors that he expects Morgan Stanley to continue to benefit from positive earnings surprises, "relatively more aggressive" capital returns and improving revenue durability. While trading comps will likely be tough in 2021, results should "remain elevated," while investment banking activity remains heightened, Goldberg contended. Citing similar reasons, the analyst also upgraded Goldman Sachs to Overweight from Equal Weight with a price target of $362, up from $270. 3. 1MDB SETTLEMENT: In a regulatory filing back in October, Goldman Sachs Group announced that it had reached settlements of governmental and regulatory investigations relating to 1Malaysia Development Berhad, or 1MDB, with the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the Board of Governors of the Federal Reserve System, the New York State Department of Financial Services, the U.K. Financial Conduct Authority, the U.K. Prudential Regulation Authority, the Singapore Attorney General's Chambers, the Singapore Commercial Affairs Department, the Monetary Authority of Singapore and the Hong Kong Securities and Futures Commission. Goldman Sachs agreed to enter into a three-year deferred prosecution agreement with the DOJ, in which a charge against the firm, one count of conspiracy to violate the Foreign Corrupt Practices Act of 1977, will be filed and later dismissed if the firm abides by the terms of the agreement. In addition, Group Inc.'s subsidiary in Malaysia, GS Malaysia, has agreed to plead guilty to one count of conspiracy to violate the FCPA. The company will pay total penalties, after crediting, of approximately $2.6B in connection with the settlements. A separate obligation to pay $606M in disgorgement has been credited and satisfied as a result of the firm's earlier settlement with the Government of Malaysia, in which the company paid a total of $2.5B, in addition to providing a $1.4B asset recovery guarantee. This brings the total payments in connection with governmental and regulatory settlements relating to 1MDB to an aggregate of approximately $5.1B. 4. SHARE REPURCHASES: Back in December, Goldman Sachs said in a statement that, "We are pleased that the results of the Federal Reserve's latest stress test demonstrate the resilience of the largest U.S. financial institutions in the midst of a devastating pandemic. Based on the results and guidance from the Federal Reserve, we intend to resume share repurchases next quarter. In the meantime, we will continue to serve our clients and help them navigate a challenging economic environment." During its last earnings conference call, Morgan Stanley had also said that it sees resuming buybacks in the first quarter 2021.

ShowHide Related Items >><<
MS Morgan Stanley
$75.22 /

-1.25 (-1.63%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

01/11/21 Citi
Bank of America upgraded to Buy from Neutral at Citi
01/11/21 Citi
Bank of America upgraded to Buy from Neutral at Citi
01/11/21 Piper Sandler
Bank of America price target raised to $36 from $28 at Piper Sandler
01/06/21 Deutsche Bank
Bank of America price target raised to $35 from $30 at Deutsche Bank
GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

01/12/21 JMP Securities
Goldman Sachs price target raised to $320 from $285 at JMP Securities
01/11/21 Piper Sandler
Goldman Sachs price target raised to $325 from $270 at Piper Sandler
01/06/21 Deutsche Bank
Goldman Sachs price target raised to $290 from $230 at Deutsche Bank
01/05/21 Wells Fargo
Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo
MS Morgan Stanley
$75.22 /

-1.25 (-1.63%)

01/11/21 Piper Sandler
Morgan Stanley price target raised to $76 from $54 at Piper Sandler
01/06/21 Deutsche Bank
Morgan Stanley price target raised to $68 from $53 at Deutsche Bank
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21 Barclays
Morgan Stanley upgraded to Overweight with $88 target at Barclays
MS Morgan Stanley
$75.22 /

-1.25 (-1.63%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

MS Morgan Stanley
$75.22 /

-1.25 (-1.63%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

MS Morgan Stanley
$75.22 /

-1.25 (-1.63%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

MS Morgan Stanley
$75.22 /

-1.25 (-1.63%)

GS Goldman Sachs
$301.05 /

-6.95 (-2.26%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

Hot Stocks
Chart Industries announces transfer from Nasdaq to NYSE » 16:01
01/18/21
01/18
16:01
01/18/21
16:01
GTLS

Chart Industries

$134.48 /

-2.5 (-1.83%)

Chart Industries…

Chart Industries announced that it intends to transfer the listing of its common stock to the New York Stock Exchange from the Nasdaq stock exchange effective February 1, 2021. Chart's common stock will continue to trade under the ticker symbol GTLS. "We are pleased to join the NYSE, the world's largest stock exchange with world-class listed companies, to further reach global investors and shareholders," stated Jill Evanko, Chart's CEO and President. "With four of our top five customers also listed on the NYSE, we believe this will enhance our exposure to them and further develop new and existing partnerships."

ShowHide Related Items >><<
GTLS Chart Industries
$134.48 /

-2.5 (-1.83%)

GTLS Chart Industries
$134.48 /

-2.5 (-1.83%)

01/06/21 Northland
Chart Industries price target raised to $137 from $104 at Northland
12/31/20 Credit Suisse
Chart Industries price target raised to $128 from $109 at Credit Suisse
12/16/20 Lake Street
Chart Industries price target raised to $134 from $111 at Lake Street
12/16/20 Craig-Hallum
Chart Industries price target raised to $147 from $107 at Craig-Hallum
GTLS Chart Industries
$134.48 /

-2.5 (-1.83%)

GTLS Chart Industries
$134.48 /

-2.5 (-1.83%)

Periodicals
Tesla says Model Y deliveries in China have officially begun » 15:45
01/18/21
01/18
15:45
01/18/21
15:45
TSLA

Tesla

$826.55 /

-17.94 (-2.12%)

Tesla announced via…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$826.55 /

-17.94 (-2.12%)

TSLA Tesla
$826.55 /

-17.94 (-2.12%)

01/15/21 Wedbush
Tesla price target raised to $950 from $715 at Wedbush
01/13/21
Fly Intel: Top five analyst initiations
01/13/21 Edward Jones
Edward Jones starts Tesla at Hold, sees leadership balanced by competition
01/13/21 Edward Jones
Tesla initiated with a Hold at Edward Jones
TSLA Tesla
$826.55 /

-17.94 (-2.12%)

  • 14
    Feb
TSLA Tesla
$826.55 /

-17.94 (-2.12%)

TSLA Tesla
$826.55 /

-17.94 (-2.12%)

TSLA Tesla
$826.55 /

-17.94 (-2.12%)

Periodicals
Lumentum in advanced talks to acquire Coherent, WSJ reports » 15:42
01/18/21
01/18
15:42
01/18/21
15:42
COHR

Coherent

$151.92 /

-3.36 (-2.16%)

, LITE

Lumentum

$106.19 /

-0.03 (-0.03%)

Lumentum Holdings (LITE)…

Lumentum Holdings (LITE) is in advanced talks to acquire Coherent (COHR) in a cash-and-stock deal that could come together as soon as this week, Cara Lombardo of Wall Street Journal reports, citing people familiar with the matter. Exact terms couldn't be learned, Lombardo adds. Reference Link

ShowHide Related Items >><<
LITE Lumentum
$106.19 /

-0.03 (-0.03%)

COHR Coherent
$151.92 /

-3.36 (-2.16%)

COHR Coherent
$151.92 /

-3.36 (-2.16%)

01/12/21 Barclays
Coherent downgraded to Underweight from Equal Weight at Barclays
11/12/20 Longbow
Coherent downgraded to Neutral ahead of transition year at Longbow
11/12/20 Longbow
Coherent downgraded to Neutral from Buy at Longbow
11/11/20
Fly Intel: Top five analyst downgrades
LITE Lumentum
$106.19 /

-0.03 (-0.03%)

01/12/21 MKM Partners
Lumentum price target raised to $138 from $120 at MKM Partners
01/12/21 Susquehanna
Susquehanna names top five M&A candidates in Semi space
01/11/21 B. Riley Securities
Lumentum price target raised to $123 from $101 at B. Riley Securities
12/15/20
Fly Intel: Top five analyst upgrades
LITE Lumentum
$106.19 /

-0.03 (-0.03%)

COHR Coherent
$151.92 /

-3.36 (-2.16%)

LITE Lumentum
$106.19 /

-0.03 (-0.03%)

LITE Lumentum
$106.19 /

-0.03 (-0.03%)

LITE Lumentum
$106.19 /

-0.03 (-0.03%)

Hot Stocks
Air Canada to resume Boeing 737 MAX commercial operations on Feb. 1 » 13:11
01/18/21
01/18
13:11
01/18/21
13:11
ACDVF

Air Canada

$0.00 /

+ (+0.00%)

, BA

Boeing

$204.29 /

-5.6 (-2.67%)

Air Canada (ACDVF) said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$204.29 /

-5.6 (-2.67%)

ACDVF Air Canada
$0.00 /

+ (+0.00%)

ACDVF Air Canada
$0.00 /

+ (+0.00%)

01/11/21 Cowen
Air Canada upgraded to Outperform from Market Perform at Cowen
01/08/21 BofA
Air Canada upgraded to Buy from Neutral at BofA
01/05/21 RBC Capital
Air Canada price target lowered to C$27 from C$30 at RBC Capital
01/04/21 Scotiabank
Air Canada price target lowered to C$29 from C$30 at Scotiabank
BA Boeing
$204.29 /

-5.6 (-2.67%)

01/04/21
Fly Intel: Top five analyst downgrades
01/04/21 Baird
Boeing elevated to Fresh Pick at Baird
01/04/21 Bernstein
Bernstein downgrades Boeing to Underperform on worsening 787 outlook
01/04/21 Bernstein
Boeing downgraded to Underperform from Market Perform at Bernstein
BA Boeing
$204.29 /

-5.6 (-2.67%)

BA Boeing
$204.29 /

-5.6 (-2.67%)

ACDVF Air Canada
$0.00 /

+ (+0.00%)

BA Boeing
$204.29 /

-5.6 (-2.67%)

BA Boeing
$204.29 /

-5.6 (-2.67%)

Initiation
Tesco reinstated with a Buy at Goldman Sachs » 13:09
01/18/21
01/18
13:09
01/18/21
13:09
TSCDY

Tesco

$0.00 /

+ (+0.00%)

Goldman Sachs analyst Rob…

Goldman Sachs analyst Rob Joyce reinstated coverage of Tesco with a Buy rating and 295 GBp price target. With the "broadest and cheapest" entry level pricing in the U.K., alongside the lowest cost to serve online orders, Tesco is well positioned to hold onto share gained from the discounters in 2020, while growing profits, Joyce tells investors in a research note.

ShowHide Related Items >><<
TSCDY Tesco
$0.00 /

+ (+0.00%)

TSCDY Tesco
$0.00 /

+ (+0.00%)

01/04/21 Barclays
Tesco reinstated with an Overweight at Barclays
01/04/21 Barclays
Tesco reinstated with an Overweight at Barclays
12/17/20 Morgan Stanley
Tesco price target raised to 287 GBp from 276 GBp at Morgan Stanley
10/23/20 Kepler Cheuvreux
Tesco downgraded to Hold from Buy at Kepler Cheuvreux
Hot Stocks
Biohaven's troriluzole did not differentiate from placebo in Alzheimer's trial » 13:06
01/18/21
01/18
13:06
01/18/21
13:06
BHVN

Biohaven Pharmaceutical

$84.76 /

-7.065 (-7.69%)

Biohaven Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$84.76 /

-7.065 (-7.69%)

BHVN Biohaven Pharmaceutical
$84.76 /

-7.065 (-7.69%)

12/29/20 Cantor Fitzgerald
Biohaven price target raised to $115 from $109 at Cantor Fitzgerald
12/23/20 Piper Sandler
Piper 'comfortable' owning Biohaven shares into Alzheimer's readout
12/15/20 H.C. Wainwright
Biohaven Pharmaceutical initiated with a Buy at H.C. Wainwright
12/07/20 SVB Leerink
Biohaven Pharmaceutical price target raised to $120 from $85 at SVB Leerink
BHVN Biohaven Pharmaceutical
$84.76 /

-7.065 (-7.69%)

  • 29
    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.